Microvesicles of osteoblasts modulate bone marrow mesenchymal stem cell-induced apoptosis to curcumin in myeloid...

Area of Science:

• Cell Biology
• Cancer Biology
• Biochemistry

Background:

• Microvesicles (MVs) mediate intercellular communication, influencing cellular functions.
• Bone marrow niche components play a role in leukemia progression and drug response.
• Leukemic cells and bone marrow stromal cells interact, affecting treatment outcomes.

Purpose of the Study:

• To investigate the role of microvesicles (MVs) in the cross-talk between leukemic cells (KG-1), bone marrow mesenchymal stem cells (BMSCs), and osteoblasts (OBs).
• To determine how MVs affect gene expression and drug-induced apoptosis in KG-1 cells treated with curcumin or daunorubicin.

Main Methods:

• Co-culture of KG-1 cells with BMSCs and/or OBs.
• Treatment of cells with curcumin or daunorubicin.
• Isolation and analysis of MVs.
• Gene expression analysis (OPN, CXCL-12, IL-6, STAT-3, VCAM-1).
• Assessment of drug-induced apoptosis in KG-1 cells.

Main Results:

• Undertreatment with curcumin or daunorubicin, via MVs from KG-1-BMSC co-cultures, downregulated survival genes (OPN, CXCL-12, IL-6, STAT-3, VCAM-1) in KG-1 cells and upregulated CXCL-12 in BMSCs.
• MVs from drug-treated OBs and co-cultures upregulated survival mediators in KG-1 cells.
• MVs from KG-1 cells or drug-treated co-cultures increased expression of OPN, CXCL-12, IL-6, STAT3, and VCAM-1 in OBs.
• MVs derived from KG-1+BMSCs+OBs reduced drug-induced apoptosis in KG-1 cells.

Conclusions:

• Microvesicle-mediated information transfer plays a significant role in the interaction between leukemic cells and bone marrow niche components.
• Osteoblasts may utilize MVs to counteract BMSC-induced apoptosis in drug-treated leukemic cells.
• Understanding MV-mediated communication is crucial for developing novel therapeutic strategies against leukemia.